Monday, December 06, 2021

NEWS

China to transfer Covid-19 vaccine technologies to other countries

China to transfer Covid-19 vaccine technologies to other countries

Beijing, Apr 21 (Prensa Latina) Chinese pharmaceutical companies are coordinating the transfer of the technologies used in the development of Covid-19 vaccines to other countries with the aim of increasing their production globally.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

Yin Weidong, CEO of Sinovac Biotech, confirmed that his company intends to transfer CoronaVac manufacturing methods to 10 countries.

Similarly, the president of CanSinoBIO, Yu Xuefeng, commented on a similar project between his corporation, Mexico and Pakistan to produce more doses of their vaccine and send them to other countries in South America and Central Asia.

To date, these and other Chinese pharmaceutical companies have exported millions of doses in bulk, and the recipient countries have taken care of packaging and distributing them.

The new initiative also includes the construction of filling and packaging lines.

China has 17 vaccines in various stages of testing and has inoculated 200 million domestic and foreign citizens with the four most advanced since last July.

China also signed agreements with several countries in the world to export the drugs and requested the World Health Organization to incorporate those from Sinovac, Sinopharm and CanSinoBio to the Covax program.

ef/llp/mem/ymr

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.